In lung adenocarcinoma, POLR2A expression strongly correlates with BCAR1 (breast cancer antiestrogen resistance protein 1) overexpression and with unfavorable clinical outcomes (Mao et al., 2020). The gene discussed is POLR2A; the disease is lung adenocarcinoma.